Ｈｅａｒｔｓｅｅｄ株式会社
Develops iPSC-derived cell therapies to regenerate heart tissue for heart failure.
219A | T
Overview
Corporate Details
- ISIN(s):
- N/A
- LEI:
- Country:
- Japan
- Address:
- 港区芝浦１丁目２番３号シーバンスＳ館５階
- Website:
- https://heartseed.jp/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Heartseed Inc. is a clinical-stage biotechnology company specializing in regenerative medicine for cardiac diseases. Founded in 2015 as a spin-off from Keio University, the company develops iPSC-derived cell therapies for severe heart failure. Its core strategy is "remuscularization," a novel approach to regenerate damaged heart tissue by transplanting highly purified cardiomyocyte spheroids. The lead pipeline product, HS-001, is an allogeneic iPSC-derived cardiomyocyte therapy administered via intramyocardial injection for patients with heart failure with reduced ejection fraction (HFrEF). Heartseed aims to provide a fundamental treatment for conditions where heart transplantation was previously the only curative option. The company also conducts research on next-generation therapies using autologous and HLA-edited iPSCs to minimize immune rejection.
This is a Fraction of the Available Data.
You're viewing a limited, static snapshot. Professionals use our API to get real-time, AI-ready data for Ｈｅａｒｔｓｅｅｄ株式会社 and 9,000+ other companies.
Stop analyzing yesterday's news. Start building a real-time advantage.
Request Enterprise API AccessFilings
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2025-06-19 09:00 |
Regulatory News Service
臨時報告書
|
Japanese | 19.9 KB | |
| 2025-06-12 08:30 |
Regulatory News Service
確認書
|
Japanese | 8.0 KB | |
| 2025-06-12 08:30 |
Interim Report
半期報告書－第10期(2024/11/01－2025/12/31)
|
Japanese | 143.9 KB | |
| 2025-01-27 02:01 |
Regulatory News Service
臨時報告書
|
Japanese | 21.3 KB | |
| 2025-01-27 02:01 |
Regulatory News Service
確認書
|
Japanese | 8.0 KB | |
| 2025-01-27 02:00 |
Annual Report
有価証券報告書－第9期(2023/11/01－2024/10/31)
|
Japanese | 6.0 MB | |
| 2025-01-27 02:00 |
Regulatory News Service
内部統制報告書－第9期(2023/11/01－2024/10/31)
|
Japanese | 21.1 KB | |
| 2024-07-22 08:18 |
Regulatory News Service
訂正有価証券届出書（新規公開時）
|
Japanese | 4.6 MB | |
| 2024-07-11 08:00 |
Regulatory News Service
訂正有価証券届出書（新規公開時）
|
Japanese | 4.6 MB | |
| 2024-06-26 08:00 |
Prospectus
有価証券届出書（新規公開時）
|
Japanese | 9.0 MB |
Automate Your Workflow. Get a real-time feed of all Ｈｅａｒｔｓｅｅｄ株式会社 filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Need More History? Access decades of standardized financials for Ｈｅａｒｔｓｅｅｄ株式会社 via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
/other/Diamyd_Medical_AB_publ-logo.png){kind=logo}
